Brucella abortus vaccines: use in control programs and immune response

dc.creatorDorneles, E. M. S.
dc.creatorOliveria, L. F.
dc.creatorLage, A. P.
dc.date2018-08-24T18:02:47Z
dc.date2018-08-24T18:02:47Z
dc.date2017
dc.date.accessioned2023-09-28T19:59:02Z
dc.date.available2023-09-28T19:59:02Z
dc.identifierDORNELES, E. M. S.; OLIVERIA, L. F.; LAGE, A. P. Brucella abortus vaccines: use in control programs and immune response. Journal of Bacteriology and Mycology, [S. l.], v. 4, n. 1, p. 1-6, 2017.
dc.identifierhttp://austinpublishinggroup.com/bacteriology/fulltext/bacteriology-v4-id1044.php
dc.identifierhttp://repositorio.ufla.br/jspui/handle/1/30164
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9041635
dc.descriptionBrucella spp. is a highly infectious pathogen that affects numerous livestock and wild animal species besides humans, and that although eradicated in some countries, remains one of the most economically important zoonosis worldwide. Strain 19 and RB51 are the two Brucella abortus vaccine strains more largely used in the control of brucellosis in cattle worldwide, being effective in the prevention of abortion and infection, besides offering long lasting protection. Here, we reviewed the main aspects of the B. abortus vaccines and their use in brucellosis control and eradication programs over the years and the current understanding in the immune response triggered by these two B. abortus vaccines, especially in cattle.
dc.languageen_US
dc.publisherAustin Publishing Group
dc.rightsrestrictAccess
dc.sourceJournal of Bacteriology and Mycology
dc.subjectBrucellosis prevention
dc.subjectBrucella Abortus - Vaccines
dc.subjectPrevenção de brucelose
dc.subjectBrucella Abortus - Vacina
dc.titleBrucella abortus vaccines: use in control programs and immune response
dc.typeArtigo


Este ítem pertenece a la siguiente institución